Does FIDAXOMICIN Cause Agranulocytosis? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Agranulocytosis have been filed in association with FIDAXOMICIN (Dificid). This represents 1.2% of all adverse event reports for FIDAXOMICIN.
18
Reports of Agranulocytosis with FIDAXOMICIN
1.2%
of all FIDAXOMICIN reports
2
Deaths
13
Hospitalizations
How Dangerous Is Agranulocytosis From FIDAXOMICIN?
Of the 18 reports, 2 (11.1%) resulted in death, 13 (72.2%) required hospitalization, and 11 (61.1%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FIDAXOMICIN. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does FIDAXOMICIN Cause?
Clostridium difficile infection (309)
Drug ineffective (302)
Diarrhoea (144)
Treatment failure (95)
No adverse event (75)
Clostridium difficile colitis (54)
Off label use (51)
Death (50)
Nausea (49)
Pyrexia (43)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which FIDAXOMICIN Alternatives Have Lower Agranulocytosis Risk?
FIDAXOMICIN vs FILGOTINIB
FIDAXOMICIN vs FILGRASTIM
FIDAXOMICIN vs FILGRASTIM-AAFI
FIDAXOMICIN vs FILGRASTIM-SNDZ
FIDAXOMICIN vs FINASTERIDE